期刊文献+

转移瘤硬膜外脊髓压迫症运动功能障碍与影像学及临床特征相关性分析 被引量:6

Single factor analysis of motor dysfunction and imaging and clinical features in metastatic epidural spinal cord compression
下载PDF
导出
摘要 目的:探讨转移瘤硬膜外脊髓压迫症(metastatic epidural spinal cord compression,MESCC)运动功能障碍与影像学及临床特征的相关性。方法:自2006年7月至2008年12月对连续收治的26例MESCC患者43个主要病变椎体进行MRI及CT扫描评估,并进行运动功能障碍评分。结果:26例MESCC患者中,12例发生内脏转移,其中10例发生运动功能障碍;14例无内脏转移,其中4例发生运动功能障碍(P=0.0079)。主要病变椎体连续组中,16椎发生运动功能障碍;主要病变椎体非连续组中,9椎发生运动功能障碍(P=0.1034)。主要病变椎体累及椎板组中,11椎发生运动功能障碍;主要病变椎体未累及椎板组中,14椎发生运动功能障碍(P=0.0205)。主要病变椎体后壁向后突出组中,12椎发生运动功能障碍;主要病变椎体后壁无向后突出组中,13椎发生运动功能障碍(P=0.0334)。侵犯椎管内硬膜外组织组中,11椎发生运动功能障碍;未侵犯椎管内硬膜外组织组中,14椎发生运动功能障碍(P=0.0036)。转移瘤患者年龄、性别、术前接受正规化疗、转移灶部位腰背部疼痛程度、原发肿瘤已行根治手术、原发肿瘤治疗效果、脊柱外骨转移灶数目、主要受累脊椎数目、主要病变椎体节段、连续病变椎体节段、累及椎体、椎体前柱骨折、椎体后壁骨折、累及椎弓根等因素对MESCC运动功能障碍影响均无统计学意义(P>0.05)。结论:发生内脏转移、主要病变椎体累及椎板、椎体后壁向后突出、转移瘤侵犯椎管内硬膜外组织的MESCC较易发生运动功能障碍,转移瘤连续病椎的发生率于颈椎和上胸椎组最高。 To explore the relationship of motor dysfunction of the lower extremities with the imaging appear- ances and clinical features of metastatic epidural spinal cord compression (MESCCs). Methods:From July 2006 to December 2007,26 successive patients with metastases of the thoracic, lumbar and the cervical spine were treated in our department. Forty-three main involved vertebra in all 26 patients were evaluated by magnetic resonance imaging and computed tomogra- phy, and were scored according motor dysfunction in this study. Fourteen patients (25 vertebrae) had motor dysfunction. Re- sults:Among 26 patients, 12 cases with visceral metastasis,in which had motor dysfunction in 10 cases; 14 cases without vis- ceral metastasis,in which had motor dysfunction in 4 cases;comparison between two groups,P=-0.007 9. Among vertebral pres- ence of continuity of 43 main involved vertebrae, 16 vertebrae had motor dysfunction ; among vertebral absence of continuity, motor dysfunction occurred in 9 vertebrae, comparison between two groups, P=0.103 4. Among vertebral presence of lamina in- volvement of 43 main involved vertebrae, 11 vertebrae had motor dysfunction ; among vertebral absence of lamina involvement, motor dysfunction occurred in 14 vertebrae, comparison between two groups,P=0.020 5. Among vertebral presence of protrud- ing of vertebral posterior wall of 43 main involved vertebrae, 12 vertebrae had motor dysfunction;among vertebral absence of protruding of vertebral posterior wall, 13 vertebrae had motor dysfunction, comparison between two groups, P=0.033 4. Among vertebral presence of involvement epidural space of 43 main involved vertebrae, 11 vertebrae had motor dysfunction ; among vertebral absence of involvement epidural space, 14 vertebrae had motor dysfunction, comparison between two groups, P=0.003 6. Such factors as age, gender, whether or not received regular chem before admission, back pain degree of metastasis, received regular chem before admission, therapeutic efficacy of primary tumor, number of bony metastases outside spine, number of the main involved vertebrae, level of vertebral metastases location, level of continuous involved vertebrae, vertebral-body involve- ment, fracture of anterior column, fracture of posterior wall, and pedicle involvement had no effects on incidence of motor dys- function due to MESCC (/:'〉0.05). Conclusion:MESCC with visceral metastases,lamina involvement,presence of outstandingbuttocks sign of posterior wall,involvement epidural space tended to cause symptomatic MESCC. Incidence of continuity of main involved vertebrae occurred more frequently in the CUTS compared with other levels of spine.
出处 《中国骨伤》 CAS 2011年第11期943-947,共5页 China Journal of Orthopaedics and Traumatology
关键词 肿瘤转移 脊髓压迫症 运动障碍 放射摄影术 脊柱 Neoplasm metastasis Spinal cord compression Movement disorders Radiography Spine
  • 相关文献

参考文献9

  • 1Cole JS,Patchell RA. Metastatic epidural spinal cord compression [J]. Lancet Nearo, 2008,7 (5) :459-466.
  • 2Venkitaraman R, Sohaib SA, Barbachano Y, et al. Detection of oc- cult spinal cord compression with magnetic resonance imaging of the spine [ J ]. Clin Oncol (R Coil Radiol), 2007,19 (7) : 528-531.
  • 3Huang J ,Jatoi A. Morbidity and mortality in patients with cancer who become nonambulatory after spinal cord compression :a case series on end-of-life care [ J ]. J Palliat Med, 2009,12 (3) :219-222.
  • 4Spiller WG. Rapidly progressive paralysis associated with carcino- ma[J]. Arch Neurol Psychiatry, 1925,13:471-477.
  • 5Venkitaraman R,Barbachano Y,Dearnaley DP,et al. Outcome of early detection and radiotherapy for occult spinal cord compression [ J ]. Radiother Oncol, 2007,85 (3) :469-472.
  • 6Markman M. Early recognition of spinal cord compression in cancer patients[J ]. Cleve Clin J Med, 1999,66 (10) : 629-631.
  • 7Jacobs WB,Perrin RG. Evaluation and treatment of spinal metas- tases : an overview[J]. Neurosurg Focus,2001,11 (6) :el0.
  • 8Yasushi H, Masaaki K,Takatoshi S. Vertebral metastases with high risk of symptomatic malignant spinal cord compression[J]. Jpn J Clin Oncol, 2009,59 (7) : 451-434.
  • 9Abdi S, Adams CI, Foweraker KL, et al. Metastatic spinal cord syn- dromes:imaging appearances and treatment planning [J ]. Clin Ra- diol, 2005,60 (6) : 637-647.

同被引文献87

  • 1闫惠淳,李晶,柳大为,荣起国,周彦恒.舌侧矫治器预置转矩弓丝对上前牙牙周膜应力影响的三维有限元研究[J].中华口腔正畸学杂志,2020,27(3):154-157. 被引量:1
  • 2张桂香,刘新兰,赵艳娇.乳腺癌骨转移临床特点及其预后影响因素的研究[J].宁夏医科大学学报,2013,35(9):987-990. 被引量:7
  • 3肖智韬,宫赫.腰椎-椎弓根螺钉固定系统的建模与有限元分析[J].医用生物力学,2009,24(S1):136-137. 被引量:2
  • 4王哲,汪正宇,王冬梅,王成焘.基于CT图像的侧凸脊柱胸腰段及骶骨整体三维有限元模型的建立[J].机械,2007,34(4):24-26. 被引量:5
  • 5Sutcliffe P,Connock M,Shyangdan D,et al. A systematic review of evidence on malignant spinal metastases:natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression[J]. Health Technol Assess,2013,17(42):1-274.
  • 6White BD,Stirling AJ,Paterson E,et al. Diagnosis and management of patients at risk of or with metastatic spinal cord compression:summary of NICE guidance[J]. BMJ,2008,337:a2538.
  • 7Quraishi NA,Gokaslan ZL,Boriani S. The surgical management of metastatic epidural compression of the spinal cord[J]. J Bone Joint Surg Br,2010,92(8):1054-1060.
  • 8Lluch A,Cueva J,Ruiz-Borrego M,et al. Zoledronic acid in the treatment of metastatic breast cancer[J]. Anticancer Drugs,2014,25(1):1-7.
  • 9Okegawa T,Higaki M,Matsumoto T,et al. Zoledronic acid improves clinical outcomes in patients with bone metastatic hormone-naíve prostate cancer in a multicenter clinical trial[J]. Anticancer Res,2014,34(8):4415-4420.
  • 10Rolfo C,Raez LE,Russo A,et al. Molecular target therapy for bone metastasis:starting a new era with denosumab,a RANKL inhibitor[J]. Expert Opin Biol Ther,2014,14(1):15-26.

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部